VeriMom4-butylresorcinol은 임신 중 안전한가요?
No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
Pregnancy-safe products containing 4-butylresorcinol
Related ingredients
Frequently asked questions
- 4-butylresorcinol은 임신 중 안전한가요?
- No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
- 4-butylresorcinol은 모유 수유 중 안전한가요?
- As for pregnancy: no evidence or regulatory classification indicating reproductive or lactation-specific hazard was found. Topical use implies low but measurable systemic exposure in adults; therefore breastfeeding exposure is considered low/measurable but no data show transfer in milk or nursing‑infant effects. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
- 4-butylresorcinol은 아기 피부에 안전한가요?
- No infant‑specific hazard or mechanistic data were identified. Per the scoring rules, because 4‑butylresorcinol has measurable dermal availability in topical formulations for adults, baby exposure is increased by +1 (immature barrier, higher surface‑area:weight), so exposure is rated moderate. No studies demonstrating infant-specific toxicity were found. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39326268/?utm_source=openai))
- VeriMom은 4-butylresorcinol을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 4-butylresorcinol을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 4-butylresorcinol 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.